Back to Journals » Clinical, Cosmetic and Investigational Dermatology » Volume 16

Risankizumab for the Treatment of Moderate to Severe Psoriasis: Impact on Health-Related Quality of Life and Psychological Wellbeing

Total article views   HTML views PDF downloads Totals
4,057 Dovepress* 3,705+ 111 3,816
PubMed Central* 352 124 476
Totals 4,057 235 4,292
*Since 25 January 2023

View citations on PubMed Central and Google Scholar